Lam, H., Nguyen, H. M., Labrecque, M. P., Brown, L. G., Coleman, I. M., Gulati, R., . . . Corey, E. (2019). Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts. Eur Urol.
Chicago Style citaatLam, Hung-Ming, et al. "Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated With a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts." Eur Urol 2019.
MLA citatieLam, Hung-Ming, et al. "Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated With a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts." Eur Urol 2019.